GO:0006862 nucleotide transport: Genes and Methods

Nucleotide transport (GO:0006862) is a fundamental biological process defined as the directed movement of a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate, into, out of or within a cell. Nucleotides such as ATP, ADP, GTP, and their derivatives are not only building blocks of nucleic acids but also universal energy carriers and signaling molecules, so their movement across membranes must be tightly controlled. This process is mediated by a diverse set of transport proteins, including mitochondrial carriers, vesicular nucleotide transporters, and ATP-binding cassette (ABC) transporters, each adapted to specific substrates and cellular compartments. Understanding nucleotide transport is critical for researchers in cell biology, biochemistry, and medicine because defects in these transport systems are linked to metabolic disorders, cardiovascular disease, and neurological dysfunction. For example, mitochondrial adenine nucleotide transport is a key determinant of cellular energy homeostasis and has been implicated in cardioprotection. Vesicular nucleotide transport controls the release of ATP as a neurotransmitter or signaling molecule, and its dysfunction may contribute to pain, inflammation, and other pathologies. In plants, adenine nucleotide transport is not limited to mitochondria but also occurs in plastids and peroxisomes, reflecting the need to coordinate energy metabolism across multiple organelles. Recent advances in structural biology and membrane transport research have revealed that nucleotide transporters use diverse mechanisms, including elevator-type alternating access and ABC transporter conformational cycles. These insights provide a framework for studying how nucleotides are recognized, translocated, and regulated, and they open new avenues for therapeutic targeting of transport proteins. This article summarizes the current understanding of nucleotide transport, its key genes and proteins, its regulation, its role in disease, and the experimental methods used to study it.

GO:0006862 nucleotide transport is defined by the Gene Ontology as the directed movement of a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate, into, out of or within a cell. In practical terms, this process encompasses the translocation of nucleotide molecules across biological membranes, whether they are moving into a cell, out of a cell, or between intracellular compartments. It includes transport steps mediated by dedicated carrier proteins, pumps, and channels, and it is distinct from nucleotide metabolism, which involves chemical conversion rather than movement.

Nucleotide transport is essential for maintaining cellular energy balance, supplying nucleotides for nucleic acid synthesis, and enabling nucleotide-based signaling. Because nucleotides such as ATP and GTP are charged molecules that cannot freely diffuse across lipid bilayers, their movement depends on specific transport proteins. Defects in these proteins can disrupt mitochondrial energy metabolism, vesicular neurotransmitter storage, and drug resistance mechanisms, making nucleotide transport a central topic in cell biology, pharmacology, and disease research.

The following genes and proteins are representative examples of factors involved in nucleotide transport, based on published literature.

Nucleotide transport is regulated at multiple levels. Mitochondrial adenine nucleotide transport is controlled by the expression levels of carrier proteins and by the cellular energy state, which determines the direction of ADP/ATP exchange. Vesicular nucleotide transport is regulated by the electrochemical gradient across the vesicle membrane and by the availability of ATP and divalent cations such as Mg2+. ABC transporters are regulated by nucleotide binding and hydrolysis, and their activity can be modulated by conformational changes in nucleotide-binding domains. In plants, nucleotide transport across plastid and peroxisomal membranes is coordinated with organellar metabolic demands. These regulatory mechanisms ensure that nucleotide movement matches cellular needs.

Mitochondrial adenine nucleotide transport is critical for cardiac energy metabolism, and its dysfunction has been linked to impaired cardioprotection and ischemic injury. Mutations or altered expression of mitochondrial carriers can disrupt ATP/ADP exchange, leading to energy failure in cardiomyocytes. Experimental models targeting these carriers help clarify their role in heart disease.

Vesicular nucleotide transporter (VNUT/SLC17A9) mediates ATP storage in secretory vesicles, and its activity is required for purinergic signaling. Dysregulation of vesicular nucleotide transport has been implicated in pain, inflammation, and other neurological conditions, making VNUT a potential drug target. Divalent cations such as Mg2+ modulate VNUT activity, which may influence disease progression.

ABC transporters that use nucleotide binding and hydrolysis to pump substrates are key players in multidrug resistance. The bacterial ABC transporter BmrA serves as a model for understanding how nucleotide-dependent conformational changes drive transport, with implications for antibiotic resistance. Targeting these transporters is a strategy to overcome resistance in pathogens and cancer cells.

Direct measurement of nucleotide transport can be performed using radioactive nucleotides (e.g., 14C-ADP or 3H-ATP) or fluorescent nucleotide analogs in isolated membranes, vesicles, or intact cells. These assays quantify uptake or release and are used to characterize transporter specificity and kinetics.

Mass spectrometry-based proteomics can identify proteins associated with nucleotide transport complexes, such as mitochondrial carriers or ABC transporters. Affinity purification followed by proteomics helps reveal interaction partners and post-translational modifications that regulate transport activity.

Cryo-electron microscopy and X-ray crystallography provide snapshots of nucleotide transporters in different states, revealing elevator-type mechanisms and ABC transporter dynamics. These methods are essential for understanding how nucleotide binding triggers conformational changes.

Knockout, knockdown, or point-mutation models generated by CRISPR-Cas9 allow researchers to test the causal role of specific transporters in nucleotide transport and downstream phenotypes. Combining these models with transport assays and imaging provides a powerful approach to study function.

Researchers studying nucleotide transport-related genes often need to determine whether a candidate gene is causally involved in nucleotide movement, energy metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.

Nucleotide transport (GO:0006862) is a fundamental biological process that ensures nucleotides are correctly distributed across cellular membranes. It relies on diverse transport proteins, including mitochondrial carriers, vesicular nucleotide transporters, and ABC transporters, each with specialized mechanisms and regulatory features. Dysregulation of nucleotide transport contributes to cardiovascular, neurological, and infectious diseases, making it a valuable target for therapeutic intervention. Continued research using advanced structural, biochemical, and CRISPR-based approaches will further illuminate how nucleotides are moved and how these processes can be modulated for clinical benefit.